pembrolizumab
merck
['key,note,716', 'keynote 716', 'melanoma']
immunologist presents on keynote 716 - a melanoma study that will better guide decision making on adjuvant therapy. monday #asco23 
NCI-designated Comprehensive Cancer Center and a global leader in cancer research and cancer care affiliated with @PittTweet